| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.031 | 0.5 |